Quidel Corporation - News Releases

2019 2018 2017 2016 2015 2014

12/19/2018

Quidel Receives CE Mark for Its Point-of-Care Sofia® Quantitative Vitamin D Assay for Use With Sofia Instrument

12/18/2018

Quidel Receives CE Mark for Point-of-Care Sofia® 2 Lyme+ Fluorescent Immunoassay for Use with Sofia 2 Instrument

12/13/2018

Quidel Announces the Availability of Triage® PLGF Assay for Use with Quidel’s Triage® MeterPro Instrumented System

12/07/2018

Quidel to Hold BNP Supply Agreement Update Conference Call on December 10, 2018

12/07/2018

Quidel Comments on California Court Ruling

11/29/2018

Quidel Receives CE Mark for TriageTrueTM High Sensitivity Troponin I Test, Its Next-Generation Diagnostic Assay for Aid in Diagnosis of Myocardial Infarction for Use with Quidel’s Triage® MeterPro Instrumented System

11/12/2018

Quidel to Present at the 30th Annual Piper Jaffray Healthcare Conference

11/06/2018

Quidel Reports Third Quarter 2018 Financial Results

10/17/2018

Quidel to Hold Third Quarter 2018 Financial Results Conference Call on November 6th, 2018

08/30/2018

Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument from Finger-Stick Whole Blood Specimens

08/07/2018

Quidel Reports Second Quarter 2018 Financial Results

07/17/2018

Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018

07/16/2018

Quidel Receives FDA Clearance for Solana® Bordetella Complete® Molecular Diagnostic Assay for the Detection of Pertussis (Whooping Cough), Parapertussis Infections

06/05/2018

Quidel to Present at William Blair 38th Annual Growth Stock Conference

05/31/2018

Quidel Announces Private Exchange Transactions

05/15/2018

Quidel to Present at UBS Global Healthcare Conference

05/08/2018

Quidel Reports First Quarter 2018 Financial Results

04/23/2018

Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018

03/27/2018

Quidel to Host 2018 Analyst and Investor Day in Chicago

03/08/2018

Quidel Announces Private Exchange Transactions

03/05/2018

Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument

02/26/2018

Quidel to Present at Upcoming Conferences

02/21/2018

Quidel Reports Fourth Quarter and Full Year 2017 Financial Results

02/13/2018

Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements

02/07/2018

Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018

01/05/2018

Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million